Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD-A Pilot Study

被引:0
作者
Karauda, Tomasz [1 ]
Milkowska-Dymanowska, Joanna [1 ]
Kumor-Kisielewska, Anna [1 ]
Piotrowski, Wojciech J. [1 ]
Bialas, Adam J. [1 ,2 ]
机构
[1] Med Univ Lodz, Dept Pneumol, PL-90419 Lodz, Poland
[2] Blessed Rafal Chylinski Mem Hosp Lung Dis, Reg Med Ctr Lung Dis & Rehabil, Dept Pulm Rehabil, PL-91520 Lodz, Poland
关键词
chronic obstructive pulmonary disease; COPD; IL-16; IL-25; survival analysis; immunopathology of COPD; PULMONARY; INFLAMMATION; IL-25; CELLS;
D O I
10.3390/jcm13175188
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exacerbation of chronic obstructive pulmonary disease (ECOPD) significantly impact health status, hospitalization rates, and disease progression, and are linked to increased mortality. Predictive factors for ECOPD are therefore of considerable interest. The limited understanding of interleukin 16 (IL-16) and IL-25 role in ECOPD provided the rationale for this study. Methods: Fifty ex-smokers diagnosed with COPD (22 ECOPD and 28 patients in the stable phase of the disease) underwent prospective analysis to evaluate the role of I IL-25 as predictive markers of clinical outcomes in ECOPD. Results: We observed a significantly lower IL-16 and higher IL-25 concentrations among ECOPD patients (p = 0.002 and p = 0.01 respectively). We also detected a significant negative correlation between IL-16 and neutrophil-to-lymphocyte ratio (NLR) (p = 0.04) and a significant negative correlation between IL-25 concentration and absolute eosinophil count (p = 0.04). In the entire group, we observed a positive correlation between IL-16 and both FEV1 and FVC, both expressed as a percentage of reference value, (p = 0.002 and p = 0.0004 respectively). However, after stratification to ECOPD and stable COPD group, significance maintained for FVC (p = 0.045 for ECOPD and p = 0.02 for stable COPD). In survival analysis, we detected significantly lower all-cause mortality for 3rd tertile of IL-16 concentrations, with a hazard ratio of 0.33 (95%CI: 0.11-0.98; p = 0.04). Conclusions: Lower IL-16 levels among ECOPD patients may indicate a feedback mechanism linked to heightened Th1 response activation. Observed correlations with ventilatory parameters and survival also seems to reflect this mechanism. The higher IL-25 concentrations observed in ECOPD patients, along with the negative correlation with absolute eosinophil count and eosinopenia, suggest multifactorial regulation and independent functions of eosinophils and IL-25. Hypothetically, this paradox may be related to the Th1/Th2 imbalance favoring Th1 response. Obtained results should be reproduced in larger size samples.
引用
收藏
页数:9
相关论文
共 32 条
  • [1] Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units
    Abidi, Khalid
    Khoudri, Ibtissam
    Belayachi, Jihane
    Madani, Naoufel
    Zekraoui, Aicha
    Zeggwagh, Amine Ali
    Abouqal, Redouane
    [J]. CRITICAL CARE, 2008, 12 (02)
  • [2] Eosinopenia, an early marker of increased mortality in critically ill medical patients
    Abidi, Khalid
    Belayachi, Jihane
    Derras, Youssef
    El Khayari, Mina
    Dendane, Tarek
    Madani, Naoufel
    Khoudri, Ibtissam
    Zeggwagh, Amine Ali
    Abouqal, Redouane
    [J]. INTENSIVE CARE MEDICINE, 2011, 37 (07) : 1136 - 1142
  • [3] Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease
    Bialas, Adam
    Kornicki, Kamil
    Ciebiada, Maciej
    Antczak, Adam
    Milkowska-Dymanowska, Joanna
    Piotrowski, Wojciech
    Gorski, Pawel
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [4] Integrative Omics Approach Identifies Interleukin-16 as a Biomarker of Emphysema
    Bowler, Russell P.
    Bahr, Timothy M.
    Hughes, Grant
    Lutz, Sharon
    Kim, Yu-Il
    Coldren, Christopher D.
    Reisdorph, Nichole
    Kechris, Katerina J.
    [J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2013, 17 (12) : 619 - 626
  • [5] COPD exacerbations: definitions and classifications
    Burge, S
    Wedzicha, JA
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 : 46S - 53S
  • [6] A549 cells can express interleukin-16 and stimulate eosinophil chemotaxis
    Cheng, G
    Ueda, T
    Eda, F
    Arima, M
    Yoshida, N
    Fukuda, T
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 25 (02) : 212 - 218
  • [7] Association between Serum Levels of Interleukin-25/Thymic Stromal Lymphopoietin and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease
    Choi, Joon Young
    Kim, Tae-Hyung
    Kang, Sung-Yoon
    Park, Hye Jung
    Lim, Seong Yong
    Kim, Sang Hyuk
    Jung, Ki-Suck
    Yoo, Kwang Ha
    Yoon, Hyoung Kyu
    Rhee, Chin Kook
    [J]. BIOMOLECULES, 2023, 13 (03)
  • [8] Interleukin-16
    Cruikshank, WW
    Kornfeld, H
    Center, DM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (06) : 757 - 766
  • [9] Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot Study
    de Torres, Juan P.
    Casanova, Ciro
    Pinto-Plata, Victor
    Varo, Nerea
    Restituto, Patricia
    Cordoba-Lanus, Elizabeth
    Baz-Davila, Rebeca
    Aguirre-Jaime, Armando
    Celli, Bartolome R.
    [J]. PLOS ONE, 2011, 6 (01):
  • [10] G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
    Faul, Franz
    Erdfelder, Edgar
    Lang, Albert-Georg
    Buchner, Axel
    [J]. BEHAVIOR RESEARCH METHODS, 2007, 39 (02) : 175 - 191